Table 4.

Unadjusted and adjusted liner regression models for factors affecting the abnormal computed tomography findings in patients with COVID-19.

	Unadjusted		Adjusted
	Regression coefficient	P-value	Regression coefficient	P-value
GGO (%)
GSDMD, log pg/mL	13.12 [−0.52, 26.75]	0.059	8.22 [−4.92, 21.37]	0.213
M30, U/L	0.0087 [−0.024, 0.041]	0.593	−0.00012 [−0.031, 0.029]	0.935
Albumin, g/dL	−4.99 [−11.12, 1.24]	0.113	−3.96 [−10.98, 3.06]	0.260
LDH, U/L	0.0087 [−0.0053, 0.023]	0.219	0.0043 [−0.0084, 0.017]	0.498
Consolidation (%)
GSDMD, log pg/mL	20.64 [11.25, 30.04]	<0.001	18.32 [8.76, 27.87]	<0.001
M30, U/L	0.0082 [−0.018, 0.035]	0.529	−0.0083 [−0.030, 0.013]	0.443
Albumin, g/dL	−10.43 [−15.62, −5.24]	<0.001	−8.88 [−13.99, −3.78]	0.001
LDH, U/L	0.0049 [−0.0064, 0.016]	0.384	0.0018 [−0.0074, 0.011]	0.697
GGO plus consolidation (%)
GSDMD, log pg/mL	33.76 [17.20, 50.32]	<0.001	26.54 [10.01, 43.07]	0.002
M30, U/L	0.017 [−0.028, 0.062]	0.446	−0.0095 [−0.047, 0.028]	0.610
Albumin, g/dL	−15.41 [−24.17, −6.66]	<0.001	−12.84 [−21.67, −4.01]	0.006
LDH, U/L	0.014 [−0.0055, 0.033]	0.159	0.0061 [−0.0099, 0.022]	0.446

β coefficient (presented as measured values with 95% confidence intervals) and P-values were calculated using a linear regression model. The final model was adjusted for GSDMD, M30, albumin, and LDH levels.

(GGO, ground glass opacity; GSDMD, gasdermin D; LDH, lactose dehydrogenase; M30, caspase-cleaved cytokeratin 18 fragment).